Clinical trial · no report yet · Phase 2
RadTARGET
Image-guided, Tumor-focused Radiotherapy Treatment in Intermediate and High-risk Prostate Cancer
- NCT06990542 ↗
- Recruiting
- University of California, San Diego
- Standard
We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Preliminary discovery
Commentary in our index that names this trial so far
Podcasts, YouTube videos and X posts we have indexed. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build.
| Channel | Found | |
|---|---|---|
| X threads | 10 | |
| YouTube | 1 |
The trial
ClinicalTrials.gov- Official title
- RAdiation Dose TAiloRing Guided by Enhanced Targeting
- Phase
- Phase 2
- Status
- Recruiting
- Conditions
- Prostate Cancer
- Interventions
- Image-guided tumor-focused radiation therapy
- Arms
- Standard of care dose radiotherapy · No intervention
- Tumor-focused radiotherapy · Experimental
- Enrollment
- 150 (estimated)
- Primary outcomes
- Acute toxicity
- Sponsor
- University of California, San Diego with Veracyte, Inc.
- Start
- Jun 9, 2025
- Primary completion
- Dec 2028 (estimated)
- Results posted
- No
- Registry record
- NCT06990542 · updated Feb 17, 2026